0 Valutazioni

ID

12650

Descrizione

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT; ODM derived from: https://clinicaltrials.gov/show/NCT00840853

collegamento

https://clinicaltrials.gov/show/NCT00840853

Keywords

  1. 07/12/15 07/12/15 -
Caricato su

7 dicembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

    Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

    Inclusion Criteria
    Descrizione

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
    Descrizione

    any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C2698589
    UMLS CUI [2]
    C0006413
    UMLS CUI [3]
    C1705576
    or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b).
    Descrizione

    or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b)

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C2698589
    UMLS CUI [2]
    C0023434
    UMLS CUI [3]
    C0024305
    UMLS CUI [4]
    C1705576
    with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
    Descrizione

    with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0543478
    UMLS CUI [2]
    C0277556
    with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
    Descrizione

    with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0153876
    UMLS CUI [2]
    C1705576
    patients with life expectancy greater than or equal to 6 weeks
    Descrizione

    life expectancy

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    patients with a karnofsky/lansky score greater than or equal to 50
    Descrizione

    karnofsky/lansky score

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    donor hiv negative
    Descrizione

    donor hiv negative

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0481430
    5. patient or parent/guardian capable of providing informed consent
    Descrizione

    informed consent

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
    Descrizione

    patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    UMLS CUI [2]
    C0428321
    UMLS CUI [3]
    C0201976
    UMLS CUI [4]
    C0019046
    pulse oximetry of greater than 90 percent on room air
    Descrizione

    pulse oximetry

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0034108
    sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
    Descrizione

    sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0700589
    available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
    Descrizione

    available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C2981182
    UMLS CUI [2]
    C0201622
    patients should have been off other investigational antiviral or antitumor therapy for one month prior to entry in this study.
    Descrizione

    study subject participation status

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers.
    Descrizione

    note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0005771
    Exclusion Criteria
    Descrizione

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    severe intercurrent infection
    Descrizione

    infection

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0009450
    evidence of graft versus host disease >grade ii
    Descrizione

    graft versus host disease

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0018133
    pregnant or lactating
    Descrizione

    pregnant or lactating

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C0006147
    history of hypersensitivity reactions to murine protein-containing products.
    Descrizione

    history of hypersensitivity reactions to murine protein-containing products.

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0020517
    UMLS CUI [2]
    C1699668
    currently taking corticosteroids for therapy of gvhd.
    Descrizione

    corticosteroids gvhd

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0149783

    Similar models

    Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    C1512693 (UMLS CUI)
    any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
    Item
    any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
    boolean
    C2698589 (UMLS CUI [1])
    C0006413 (UMLS CUI [2])
    C1705576 (UMLS CUI [3])
    or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b)
    Item
    or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b).
    boolean
    C2698589 (UMLS CUI [1])
    C0023434 (UMLS CUI [2])
    C0024305 (UMLS CUI [3])
    C1705576 (UMLS CUI [4])
    with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
    Item
    with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
    boolean
    C0543478 (UMLS CUI [1])
    C0277556 (UMLS CUI [2])
    with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
    Item
    with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
    boolean
    C0153876 (UMLS CUI [1])
    C1705576 (UMLS CUI [2])
    life expectancy
    Item
    patients with life expectancy greater than or equal to 6 weeks
    boolean
    C0023671 (UMLS CUI [1])
    karnofsky/lansky score
    Item
    patients with a karnofsky/lansky score greater than or equal to 50
    boolean
    C0206065 (UMLS CUI [1])
    donor hiv negative
    Item
    donor hiv negative
    boolean
    C0481430 (UMLS CUI [1])
    informed consent
    Item
    5. patient or parent/guardian capable of providing informed consent
    boolean
    C0021430 (UMLS CUI [1])
    patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
    Item
    patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
    boolean
    C1278039 (UMLS CUI [1])
    C0428321 (UMLS CUI [2])
    C0201976 (UMLS CUI [3])
    C0019046 (UMLS CUI [4])
    pulse oximetry
    Item
    pulse oximetry of greater than 90 percent on room air
    boolean
    C0034108 (UMLS CUI [1])
    sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
    Item
    sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
    boolean
    C0700589 (UMLS CUI [1])
    available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
    Item
    available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
    boolean
    C2981182 (UMLS CUI [1])
    C0201622 (UMLS CUI [2])
    study subject participation status
    Item
    patients should have been off other investigational antiviral or antitumor therapy for one month prior to entry in this study.
    boolean
    C2348568 (UMLS CUI [1])
    note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers
    Item
    note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers.
    boolean
    C0005771 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    infection
    Item
    severe intercurrent infection
    boolean
    C0009450 (UMLS CUI [1])
    graft versus host disease
    Item
    evidence of graft versus host disease >grade ii
    boolean
    C0018133 (UMLS CUI [1])
    pregnant or lactating
    Item
    pregnant or lactating
    boolean
    C0032961 (UMLS CUI [1,1])
    C0006147 (UMLS CUI [1,2])
    history of hypersensitivity reactions to murine protein-containing products.
    Item
    history of hypersensitivity reactions to murine protein-containing products.
    boolean
    C0020517 (UMLS CUI [1])
    C1699668 (UMLS CUI [2])
    corticosteroids gvhd
    Item
    currently taking corticosteroids for therapy of gvhd.
    boolean
    C0149783 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial